Daniel Sessler, MD

Appointed
2005

Education & Fellowships

Residency - University of California Los Angeles Medical Center
Anesthesiology
Los Angeles, CA USA
1985

Residency - University of California Los Angeles Medical Center (UCLA)
Pediatrics
Los Angeles, CA USA
1983

Internship - University of California Los Angeles Medical Center
Pediatrics
Los Angeles, CA USA
1981

Medical Education - Columbia University College of Physicians & Surgeons at Harlem Hospital Center
New York, NY USA
1980

Undergraduate - University of California-Berkeley
Berkeley, CA USA
1976

Professional Highlights

• Founded and directs the Outcomes Research Consortium, anesthesia's largest and most productive clinical research organization (www.OR.org)
• Published more than 600 full research papers, one book, more than 35 reviews, more than 25 book chapters and more than 25 editorials
• Trained more than 100 research fellows, five of whom subsequently chaired anesthesia departments; trained 12 graduate students, each of whom subsequently attended medical school
• Invited lectures at more than 300 institutions, including 16 eponymous lectureships
• More than $35 million in grant funding, mostly peer-reviewed

Certifications

• Pediatrics
• Anesthesiology

Specialty Interests

Department of outcomes research and the associated outcomes research consortium, general anesthesia

Awards & Honors

• Phi Beta Kappa
• Brown Fellowship in Tropical Medicine (3 months in Liberia)
• Anesthesiology Educational Foundation Essay Award
• MHAUS Certificate of Recognition
• J. William Fulbright Scholar
• ÖGARI Anesthesia Research Prize ($3,000)
• Schülke Prize ($9,000, shared with A. Kurz and R. Lenhardt)
• ANZCA Ellis Gillespie Foundation Visitor Award, Australia
• Distinguished University Scholar, University of Louisville
• Research!Louisville, First Place Faculty Award ($500)
• ASA Excellence in Research Award ($4,000)
• Alpha Omega Alpha Distinguished Faculty
• Academy of Anesthesiology Mentors
• Bernard Eliasberg Awar
• 16 Eponomous lectures

Innovations & Patents

• Detection of cancer in subject from biological sample previously withdrawn from subject involves determining in vitro level of biomarker in biological sample, where biomarker includes phospholipid or free fatty acid.US2015008314-A1
• WO2013112836-A2
• WO2013112836-A3

Memberships

• Alpha Omega Alpha Medical Honor Society Fulbright Association
• Association of University Anesthesiologists
• American Society of Anesthesiologists
• American Society of Clinical Investigation
• Association of Clinical Research Professionals
• International Anesthesia Research Society
• Malignant Hyperthermia Association of the United States
• American Physiological Society
• Association for Patient-Oriented Research
• Academy of Pharmaceutical Physicians and Investigators
• European Society of Anesthesiologists
• Society for Ambulatory Anesthesia
• Society for Clinical Trials
• International Society for Anesthetic

See publications for Daniel Sessler, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 4/5/2023, Dr. Sessler has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting and/or Speaking. Dr. Sessler receives fees of $5,000 or more per year (or, in rare cases, equity or stock options) as a paid consultant, speaker or as a member of an advisory committee for the following companies:

• G6 Data Sciences
• Blue Spark Technologies, Inc.
• Medasense Biometrics Ltd.
• Edwards Lifesciences LLC

Donation of Financial Interest. Dr. Sessler has consulted for, received compensation for serving as a fiduciary from, or received royalties from the following companies but instructed them to donate all compensation to not-for-profit causes or to the Cleveland Clinic to support research and education:

• 3M Company

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.